Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-30 · accession 0001883850-22-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-04-01 | 2022-03-30 | REGN | VAGELOS P ROY | Dir | S - Sale | $700.01 | -28.6K | 23.5K | -55% | -$20.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-30 | S | D | 14,286 | $700.02 | 127,006 | I by CLAT | — | — | (F2) Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-03-30 | S | D | 14,286 | $700.00 | 23,461 | I by Spouse as Trustee | — | — | (F3) Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price. |